Literature DB >> 29739905

Loss of Ethanolamine Utilization in Enterococcus faecalis Increases Gastrointestinal Tract Colonization.

Karan Gautam Kaval1, Kavindra V Singh2, Melissa R Cruz1, Sruti DebRoy1, Wade C Winkler3, Barbara E Murray1,2,4, Danielle A Garsin5,4.   

Abstract

Enterococcus faecalis is paradoxically a dangerous nosocomial pathogen and a normal constituent of the human gut microbiome, an environment rich in ethanolamine. E. faecalis carries the eut (ethanolamine utilization) genes, which enable the catabolism of ethanolamine (EA) as a valuable source of carbon and/or nitrogen. EA catabolism was previously shown to contribute to the colonization and growth of enteric pathogens, such as Salmonella enterica serovar Typhimurium and enterohemorrhagic Escherichia coli (EHEC), in the gut environment. We tested the ability of eut mutants of E. faecalis to colonize the gut using a murine model of gastrointestinal (GI) tract competition and report the surprising observation that these mutants outcompete the wild-type strain.IMPORTANCE Some bacteria that are normal, harmless colonizers of the human body can cause disease in immunocompromised patients, particularly those that have been heavily treated with antibiotics. Therefore, it is important to understand the factors that promote or negate these organisms' ability to colonize. Previously, ethanolamine, found in high concentrations in the GI tract, was shown to promote the colonization and growth of bacteria associated with food poisoning. Here, we report the surprising, opposite effect of ethanolamine utilization on the commensal colonizer E. faecalis, namely, that loss of this metabolic capacity made it a better colonizer.
Copyright © 2018 Kaval et al.

Entities:  

Keywords:  Enterococcus; ethanolamine; intestinal colonization

Mesh:

Substances:

Year:  2018        PMID: 29739905      PMCID: PMC5941071          DOI: 10.1128/mBio.00790-18

Source DB:  PubMed          Journal:  MBio            Impact factor:   7.867


OBSERVATION

Ethanolamine (EA) is a compound found in the gastrointestinal (GI) tract at concentrations of 1 to 2 mM (1, 2). Interestingly, the genes that code for the catabolism of this compound, the eut (ethanolamine utilization) genes, are associated with gut pathogens, including species of Escherichia, Salmonella, Clostridium, and Listeria (3). In species such as Salmonella enterica serovar Typhimurium and enterohemorrhagic Escherichia coli (EHEC), mutants lacking the ability to sense and/or catabolize EA are outcompeted by wild-type strains in the gastrointestinal tract (1, 2, 4) or display neutral colonization efficacy in the case of Clostridium difficile (5). Enterococcus faecalis also encodes the eut genes and is found in the GI tract, but unlike the above-mentioned examples, it is considered a commensal colonizer rather than a gut pathogen of healthy people. However, the presence of E. faecalis in the GI tract can serve as a source of nosocomial infection (6). Therefore, understanding the factors that promote the colonization and growth of E. faecalis in the gut is important for the development of strategies to mitigate these infections. To investigate the role of EA in GI tract colonization, we first tested OG1RF, a wild-type strain of E. faecalis commonly used in animal models (7), and an isogenic ΔeutVW mutant that lacks the two-component system that senses EA (8). EutW is a sensor histidine kinase that, upon binding EA, autophosphorylates and then phosphotransfers to EutV the cognate RNA binding response regulator that activates eut gene expression by an antitermination mechanism (8, 9). The ΔeutVW mutant does not express the eut genes and cannot utilize EA (8, 9). The strains were competed in a murine GI tract model in which the animals were pretreated with an antibiotic cocktail designed to reduce the endogenous flora and facilitate E. faecalis colonization (10). To measure levels of colonization, fecal pellets were collected at 1, 2, and 3 days postinoculation and plated for numbers of CFU on medium selective for enterococci. Fecal pellets were also collected at 4 h to check for a spike in CFU, indicating a failure to colonize. Ten colonies/mouse/time point were screened by PCR for the presence of the deletion that marked the ΔeutVW mutant strain. As shown in Fig. 1A, the ΔeutVW mutant significantly outcompeted the wild type at all colonization time points.
FIG 1 

Competitive colonization of the gastrointestinal tract by the E. faecalis wild type and mutant strains following combined inoculation. Percentages of CFU of E. faecalis strains from the initial inoculum mix and from stool samples collected 4 h and 1, 2, and 3 days after mixed inoculation of E. faecalis OG1RF and the ΔeutVW mutant (AR2) (A), OG1RF::gfp and the ΔeutVW mutant (AR2) (B), OG1RF::gfp and the ΔeutV mutant (SD54) (C), and OG1RF::gfp and the ΔeutV::P eutV mutant (SD209) (D). In panel A, 10 CFU per mouse per time point were randomly picked and PCR screened to confirm the strains’ identities. For panels B, C, and D, >100 CFU were scored for GFP fluorescence per mouse per time point. An unpaired t test with Welch’s correction for the percentages of bacteria recovered from the stool samples versus the amounts in the initial inoculum mixture was used to calculate the P values.

Competitive colonization of the gastrointestinal tract by the E. faecalis wild type and mutant strains following combined inoculation. Percentages of CFU of E. faecalis strains from the initial inoculum mix and from stool samples collected 4 h and 1, 2, and 3 days after mixed inoculation of E. faecalis OG1RF and the ΔeutVW mutant (AR2) (A), OG1RF::gfp and the ΔeutVW mutant (AR2) (B), OG1RF::gfp and the ΔeutV mutant (SD54) (C), and OG1RF::gfp and the ΔeutV::P eutV mutant (SD209) (D). In panel A, 10 CFU per mouse per time point were randomly picked and PCR screened to confirm the strains’ identities. For panels B, C, and D, >100 CFU were scored for GFP fluorescence per mouse per time point. An unpaired t test with Welch’s correction for the percentages of bacteria recovered from the stool samples versus the amounts in the initial inoculum mixture was used to calculate the P values. Because screening the colonies by PCR was labor-intensive, we decided to repeat the experiment using a previously generated marked strain of OG1RF that constitutively expresses gfp present as a chromosomal insertion (11). By exposing the plated colonies from the fecal pellets to a fluorescent stereoscope, the presence of green fluorescent protein (GFP) could easily be discerned, allowing hundreds of colonies from each mouse to be screened. To ensure that GFP expression did not deleteriously affect the fitness of our wild-type strain, it was competed against the parent strain lacking the marker; a significant difference was not observed (see Fig. S1 in the supplemental material). We repeated the competition experiment with the ΔeutVW mutant versus the wild type and again observed the mutant outcompeting the wild-type strain (Fig. 1B). Note that the inoculum of the ΔeutVW mutant was purposely kept lower than that of the wild type so as not to create a bias toward the mutant, since the first experiment indicated that it was more fit. Colonization of the gastrointestinal tract by OG1RF versus OG1RF::gfp following mixed inoculation. Numbers of CFU (A) and calculated percentages of CFU (B) of E. faecalis strains from stool samples collected at 4 h and 1, 2, and 3 days after combined inoculation. More than 100 CFU were scored for GFP fluorescence per mouse per time point. An unpaired t test with Welch’s correction for the percentages of bacteria recovered from the stool samples versus the amounts in the initial inoculum mixture was used to calculate the P values. Download FIG S1, EPS file, 0.7 MB. Considering that EA utilization mutants in other studied bacterial species tended to be less fit in the GI tract, our results showing that an E. faecalis mutant was modestly more fit were surprising. To confirm the finding, we tested a different mutant containing an in-frame deletion of only eutV. Also examined was a complement of this strain, able to induce eut gene expression to levels just slightly lower than those induced by the wild type (11). As shown in Fig. 1C, the ΔeutV mutant outcompeted the wild type at all time points examined, in contrast to the complemented strain (Fig. 1D). The eut genes in EHEC and S. Typhimuirum are regulated by a mechanism different from that found in E. faecalis. These bacteria encode an EA-sensing transcriptional activator called EutR (12). In addition to the eut genes, EutR was found to bind promoters and directly activate the expression of some virulence factors in these pathogens (13, 14). Because of this additional activity, loss of the regulator resulted in a more severe phenotype than loss of just ethanolamine catabolism, depending on the specifics of the host environment (4). We wondered whether the phenotype observed with the loss of EutV was related solely to its role in regulating genes related to EA catabolism or whether it, like EutR, perhaps had a broader role. To address this question, we created an in-frame deletion, ΔeutBC, to remove the genes encoding the two subunits of the ethanolamine ammonia lyase, which carries out the first reaction in the breakdown of EA. Many attempts to generate a complement of this mutant failed. Therefore, we created a different, independent mutant by generating a stop codon in eutB, called eutBL3*. Neither the in-frame deletion nor the stop mutant disrupted expression of the downstream eut structural genes, as bacterial microcompartment formation was still observed in both mutants (Fig. S2). Both mutants significantly outcompeted the wild type on days 2 and 3, with the stop codon mutant also displaying significant differences on day 1 (Fig. 2A and B). To test whether loss of EA sensing resulted in a greater fitness increase than loss of EA catabolism, we competed a ΔeutVW strain marked with GFP against the ΔeutBC strains (Fig. 2C and D). A significant difference was not observed for either strain pair at any time point. The data support the conclusion that EA catabolism alone contributes to the phenotype. These data fit former observations that the regulatory sequences recognized by E. faecalis EutV are found only in the eut transcripts (9).
FIG 2 

Murine gastrointestinal tract colonization by different E. faecalis strains following mixed inoculation. Percentages of CFU of E. faecalis strains from the initial inoculum mix and from stool samples collected 4 h and 1, 2, and 3 days after mixed inoculation of E. faecalis OG1RF::gfp (SD234) with the ΔeutBC strain (EFKK4) (A), OG1RF::gfp with the eutB mutant (eutBL3*) (EFKK12) (B), the ΔeutVW::gfp mutant (EFKK1) with the ΔeutBC mutant (C), and the ΔeutVW::gfp mutant with the eutB mutant (eutBL3*) (D). More than 100 CFU were scored for GFP fluorescence per mouse per time point. P values were calculated using an unpaired t test with Welch’s correction for the percentages of bacteria recovered from the fecal samples versus the amounts in the initial mixed inoculum.

Bacterial microcompartment formation in E. faecalis mutant strains. Transmission electron micrographs showing the formation of bacterial microcompartments (indicated by white arrows) in E. faecalis OG1RF (wild type), the ΔeutBC mutant (EFKK4), and the eutB mutant (eutBL3*) (EFKK12), when grown under inducing conditions. Download FIG S2, EPS file, 3.5 MB. Supplemental materials and methods. Download TEXT S1, DOCX file, 0.03 MB. Murine gastrointestinal tract colonization by different E. faecalis strains following mixed inoculation. Percentages of CFU of E. faecalis strains from the initial inoculum mix and from stool samples collected 4 h and 1, 2, and 3 days after mixed inoculation of E. faecalis OG1RF::gfp (SD234) with the ΔeutBC strain (EFKK4) (A), OG1RF::gfp with the eutB mutant (eutBL3*) (EFKK12) (B), the ΔeutVW::gfp mutant (EFKK1) with the ΔeutBC mutant (C), and the ΔeutVW::gfp mutant with the eutB mutant (eutBL3*) (D). More than 100 CFU were scored for GFP fluorescence per mouse per time point. P values were calculated using an unpaired t test with Welch’s correction for the percentages of bacteria recovered from the fecal samples versus the amounts in the initial mixed inoculum. In conclusion, we present the surprising observation that EA catabolism in E. faecalis modestly reduces GI tract colonization efficiency, in contrast to that observed for three gut pathogens (1, 2, 4, 5). The difference might arise from lifestyle, as E. faecalis is a normal gut commensal in mammals; in Caenorhabditis elegans, which E. faecalis kills, a eut mutant was attenuated (15). A deeper understanding awaits further investigation.
  14 in total

1.  EutR is a direct regulator of genes that contribute to metabolism and virulence in enterohemorrhagic Escherichia coli O157:H7.

Authors:  Deborah H Luzader; David E Clark; Laura A Gonyar; Melissa M Kendall
Journal:  J Bacteriol       Date:  2013-08-30       Impact factor: 3.490

2.  Induced cell aggregation and mating in Streptococcus faecalis: evidence for a bacterial sex pheromone.

Authors:  G M Dunny; B L Brown; D B Clewell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

3.  Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota.

Authors:  Parameth Thiennimitr; Sebastian E Winter; Maria G Winter; Mariana N Xavier; Vladimir Tolstikov; Douglas L Huseby; Torsten Sterzenbach; Renée M Tsolis; John R Roth; Andreas J Bäumler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

4.  Enterohaemorrhagic Escherichia coli gains a competitive advantage by using ethanolamine as a nitrogen source in the bovine intestinal content.

Authors:  Yolande Bertin; J P Girardeau; F Chaucheyras-Durand; Bernard Lyan; Estelle Pujos-Guillot; Josée Harel; Christine Martin
Journal:  Environ Microbiol       Date:  2010-09-16       Impact factor: 5.491

5.  Comparative genomics of ethanolamine utilization.

Authors:  Olga Tsoy; Dmitry Ravcheev; Arcady Mushegian
Journal:  J Bacteriol       Date:  2009-09-25       Impact factor: 3.490

6.  Gastrointestinal Tract Colonization Dynamics by Different Enterococcus faecium Clades.

Authors:  Maria Camila Montealegre; Kavindra V Singh; Barbara E Murray
Journal:  J Infect Dis       Date:  2015-12-15       Impact factor: 5.226

7.  Multiple posttranscriptional regulatory mechanisms partner to control ethanolamine utilization in Enterococcus faecalis.

Authors:  Kristina A Fox; Arati Ramesh; Jennifer E Stearns; Agathe Bourgogne; Angelica Reyes-Jara; Wade C Winkler; Danielle A Garsin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

8.  Ethanolamine is a valuable nutrient source that impacts Clostridium difficile pathogenesis.

Authors:  Kathryn L Nawrocki; Daniela Wetzel; Joshua B Jones; Emily C Woods; Shonna M McBride
Journal:  Environ Microbiol       Date:  2018-02-09       Impact factor: 5.491

9.  The mechanism for RNA recognition by ANTAR regulators of gene expression.

Authors:  Arati Ramesh; Sruti DebRoy; Jonathan R Goodson; Kristina A Fox; Herbey Faz; Danielle A Garsin; Wade C Winkler
Journal:  PLoS Genet       Date:  2012-06-07       Impact factor: 5.917

Review 10.  Ethanolamine Utilization in Bacteria.

Authors:  Karan Gautam Kaval; Danielle A Garsin
Journal:  MBio       Date:  2018-02-20       Impact factor: 7.867

View more
  9 in total

Review 1.  Colonization of the mammalian intestinal tract by enterococci.

Authors:  Leou Ismael Banla; Nita H Salzman; Christopher J Kristich
Journal:  Curr Opin Microbiol       Date:  2018-11-13       Impact factor: 7.934

2.  The Phosphatase Bph and Peptidyl-Prolyl Isomerase PrsA Are Required for Gelatinase Expression and Activity in Enterococcus faecalis.

Authors:  Julia L E Willett; Ethan B Robertson; Gary M Dunny
Journal:  J Bacteriol       Date:  2022-06-03       Impact factor: 3.476

3.  Genome-Wide Mutagenesis Identifies Factors Involved in Enterococcus faecalis Vaginal Adherence and Persistence.

Authors:  Norhan Alhajjar; Anushila Chatterjee; Brady L Spencer; Lindsey R Burcham; Julia L E Willett; Gary M Dunny; Breck A Duerkop; Kelly S Doran
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

4.  Complex Bacterial Consortia Reprogram the Colitogenic Activity of Enterococcus faecalis in a Gnotobiotic Mouse Model of Chronic, Immune-Mediated Colitis.

Authors:  Isabella Lengfelder; Irina G Sava; Jonathan J Hansen; Karin Kleigrewe; Jeremy Herzog; Klaus Neuhaus; Thomas Hofmann; R Balfour Sartor; Dirk Haller
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

5.  Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts.

Authors:  Julien Delmas; Lucie Gibold; Tiphanie Faïs; Sylvine Batista; Martin Leremboure; Clara Sinel; Emilie Vazeille; Vincent Cattoir; Anthony Buisson; Nicolas Barnich; Guillaume Dalmasso; Richard Bonnet
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

Review 6.  Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere.

Authors:  Fernando Baquero; Val F Lanza; Maria-Rosario Baquero; Rosa Del Campo; Daniel A Bravo-Vázquez
Journal:  Front Microbiol       Date:  2019-10-09       Impact factor: 5.640

7.  Parallel quorum-sensing system in Vibrio cholerae prevents signal interference inside the host.

Authors:  Samit Watve; Kelsey Barrasso; Sarah A Jung; Kristen J Davis; Lisa A Hawver; Atul Khataokar; Ryan G Palaganas; Matthew B Neiditch; Lark J Perez; Wai-Leung Ng
Journal:  PLoS Pathog       Date:  2020-02-14       Impact factor: 6.823

8.  An RNA-centric global view of Clostridioides difficile reveals broad activity of Hfq in a clinically important gram-positive bacterium.

Authors:  Manuela Fuchs; Vanessa Lamm-Schmidt; Johannes Sulzer; Falk Ponath; Laura Jenniches; Joseph A Kirk; Robert P Fagan; Lars Barquist; Jörg Vogel; Franziska Faber
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 11.205

9.  Ethanolamine Influences Human Commensal Escherichia coli Growth, Gene Expression, and Competition with Enterohemorrhagic E. coli O157:H7.

Authors:  Carol A Rowley; Christopher J Anderson; Melissa M Kendall
Journal:  MBio       Date:  2018-10-02       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.